Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Myriad Genetics (MYGN) over the last 16 years, with Q3 2025 value amounting to $353.6 million.

  • Myriad Genetics' Total Non-Current Liabilities rose 1214.72% to $353.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $353.6 million, marking a year-over-year increase of 1214.72%. This contributed to the annual value of $324.3 million for FY2024, which is 71.43% up from last year.
  • Myriad Genetics' Total Non-Current Liabilities amounted to $353.6 million in Q3 2025, which was up 1214.72% from $287.3 million recorded in Q2 2025.
  • Myriad Genetics' Total Non-Current Liabilities' 5-year high stood at $440.6 million during Q2 2023, with a 5-year trough of $235.1 million in Q2 2022.
  • Its 5-year average for Total Non-Current Liabilities is $330.2 million, with a median of $320.8 million in 2021.
  • Per our database at Business Quant, Myriad Genetics' Total Non-Current Liabilities crashed by 4492.86% in 2022 and then skyrocketed by 8740.96% in 2023.
  • Quarter analysis of 5 years shows Myriad Genetics' Total Non-Current Liabilities stood at $320.8 million in 2021, then dropped by 16.15% to $269.0 million in 2022, then rose by 19.7% to $322.0 million in 2023, then grew by 0.71% to $324.3 million in 2024, then grew by 9.03% to $353.6 million in 2025.
  • Its last three reported values are $353.6 million in Q3 2025, $287.3 million for Q2 2025, and $299.2 million during Q1 2025.